DrugPatentWatch Database Preview
Pexidartinib hydrochloride - Generic Drug Details
What are the generic sources for pexidartinib hydrochloride and what is the scope of freedom to operate?
Pexidartinib hydrochloride
is the generic ingredient in one branded drug marketed by Daiichi Sankyo Inc and is included in one NDA. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.Pexidartinib hydrochloride has one hundred and twenty-one patent family members in forty-one countries.
One supplier is listed for this compound.
Summary for pexidartinib hydrochloride
| International Patents: | 121 |
| US Patents: | 12 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Clinical Trials: | 12 |
| Patent Applications: | 8 |
| DailyMed Link: | pexidartinib hydrochloride at DailyMed |
Recent Clinical Trials for pexidartinib hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Daiichi Sankyo Co., Ltd. | Phase 2 |
| Daiichi Sankyo Co., Ltd. | Phase 3 |
| Daiichi Sankyo, Inc. | Phase 4 |
US Patents and Regulatory Information for pexidartinib hydrochloride
International Patents for pexidartinib hydrochloride
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200903458 | ⤷ Free Forever Trial |
| Japan | 2020528884 | ⤷ Free Forever Trial |
| Australia | 2018307910 | ⤷ Free Forever Trial |
| Japan | 2018021055 | ⤷ Free Forever Trial |
| European Patent Office | 3581573 | ⤷ Free Forever Trial |
| Japan | 2010510321 | ⤷ Free Forever Trial |
| South Korea | 20090083469 | ⤷ Free Forever Trial |
| >Country | >Patent Number | >Estimated Expiration |
